Literature DB >> 16112947

Pharmacology of estrogens and progestogens: influence of different routes of administration.

H Kuhl1.   

Abstract

This review comprises the pharmacokinetics and pharmacodynamics of natural and synthetic estrogens and progestogens used in contraception and therapy, with special consideration of hormone replacement therapy. The paper describes the mechanisms of action, the relation between structure and hormonal activity, differences in hormonal pattern and potency, peculiarities in the properties of certain steroids, tissue-specific effects, and the metabolism of the available estrogens and progestogens. The influence of the route of administration on pharmacokinetics, hormonal activity and metabolism is presented, and the effects of oral and transdermal treatment with estrogens on tissues, clinical and serum parameters are compared. The effects of oral, transdermal (patch and gel), intranasal, sublingual, buccal, vaginal, subcutaneous and intramuscular administration of estrogens, as well as of oral, vaginal, transdermal, intranasal, buccal, intramuscular and intrauterine application of progestogens are discussed. The various types of progestogens, their receptor interaction, hormonal pattern and the hormonal activity of certain metabolites are described in detail. The structural formulae, serum concentrations, binding affinities to steroid receptors and serum binding globulins, and the relative potencies of the available estrogens and progestins are presented. Differences in the tissue-specific effects of the various compounds and regimens and their potential implications with the risks and benefits of hormone replacement therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112947     DOI: 10.1080/13697130500148875

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  139 in total

Review 1.  Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol.

Authors:  Alesia V Prakapenka; Heather A Bimonte-Nelson; Rachael W Sirianni
Journal:  Ann Biomed Eng       Date:  2017-06-20       Impact factor: 3.934

2.  Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.

Authors:  Sarah E Mennenga; Stephanie V Koebele; Abeer A Mousa; Tanya J Alderete; Candy W S Tsang; Jazmin I Acosta; Bryan W Camp; Laurence M Demers; Heather A Bimonte-Nelson
Journal:  Steroids       Date:  2014-08-23       Impact factor: 2.668

3.  Contrasting effects of individual versus combined estrogen and progestogen regimens as working memory load increases in middle-aged ovariectomized rats: one plus one does not equal two.

Authors:  Alesia V Prakapenka; Ryoko Hiroi; Alicia M Quihuis; Catie Carson; Shruti Patel; Claire Berns-Leone; Carly Fox; Rachael W Sirianni; Heather A Bimonte-Nelson
Journal:  Neurobiol Aging       Date:  2017-12-07       Impact factor: 4.673

Review 4.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

5.  Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.

Authors:  Renate Louw-du Toit; Meghan S Perkins; Janet P Hapgood; Donita Africander
Journal:  Biochem Biophys Res Commun       Date:  2017-07-12       Impact factor: 3.575

6.  Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Authors:  Yolanda R Smith; Christian S Stohler; Thomas E Nichols; Joshua A Bueller; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 7.  A heartfelt message, estrogen replacement therapy: use it or lose it.

Authors:  Robert C Speth; Mikayla D'Ambra; Hong Ji; Kathryn Sandberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

8.  Hormonal contraception--what kind, when, and for whom?

Authors:  Inka Wiegratz; Christian J Thaler
Journal:  Dtsch Arztebl Int       Date:  2011-07-18       Impact factor: 5.594

9.  Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

Review 10.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.